drugset / Trial / NCT00217165

Taurine as an Anti-Manic Agent: A Double-Blind, Placebo-Controlled Study

NCT00217165

Phase 2 Completed 60 enrolled Mclean Hospital
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to determine whether the amino acid taurine has effects on mood stability in bipolar disorder.

Timeline

Start
2005-04
Primary completion
2010-01
Completion
2011-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Taurine Other / unclassified 2 mg Oral